Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-trace').style.display = (document.getElementById('cakeErr680dba10ae928-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680dba10ae928-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-code').style.display = (document.getElementById('cakeErr680dba10ae928-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-context').style.display = (document.getElementById('cakeErr680dba10ae928-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680dba10ae928-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680dba10ae928-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 13880, 'metaTitle' => 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'metaKeywords' => 'Tuberculosis,Health', 'metaDesc' => ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...', 'disp' => '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 13880 $metaTitle = 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar' $metaKeywords = 'Tuberculosis,Health' $metaDesc = ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...' $disp = '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar | Im4change.org</title> <meta name="description" content=" The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>India contests WHO figures for multi-drug resistant TB-Aarti Dhar</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-trace').style.display = (document.getElementById('cakeErr680dba10ae928-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680dba10ae928-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-code').style.display = (document.getElementById('cakeErr680dba10ae928-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-context').style.display = (document.getElementById('cakeErr680dba10ae928-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680dba10ae928-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680dba10ae928-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 13880, 'metaTitle' => 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'metaKeywords' => 'Tuberculosis,Health', 'metaDesc' => ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...', 'disp' => '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 13880 $metaTitle = 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar' $metaKeywords = 'Tuberculosis,Health' $metaDesc = ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...' $disp = '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar | Im4change.org</title> <meta name="description" content=" The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>India contests WHO figures for multi-drug resistant TB-Aarti Dhar</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-trace').style.display = (document.getElementById('cakeErr680dba10ae928-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680dba10ae928-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-code').style.display = (document.getElementById('cakeErr680dba10ae928-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680dba10ae928-context').style.display = (document.getElementById('cakeErr680dba10ae928-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680dba10ae928-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680dba10ae928-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 13880, 'metaTitle' => 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'metaKeywords' => 'Tuberculosis,Health', 'metaDesc' => ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...', 'disp' => '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 13880 $metaTitle = 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar' $metaKeywords = 'Tuberculosis,Health' $metaDesc = ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...' $disp = '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 &mdash; the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States &mdash; Gujarat, Maharashtra, Andhra Pradesh &mdash; which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar | Im4change.org</title> <meta name="description" content=" The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>India contests WHO figures for multi-drug resistant TB-Aarti Dhar</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 13880, 'metaTitle' => 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'metaKeywords' => 'Tuberculosis,Health', 'metaDesc' => ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...', 'disp' => '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 13880, 'title' => 'India contests WHO figures for multi-drug resistant TB-Aarti Dhar', 'subheading' => '', 'description' => '<div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Periodical exercise</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> <em>Global annual incidence</em> </div> <div style="text-align: justify"> <br /> </div> <div style="text-align: justify"> Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus. </div>', 'credit_writer' => 'The Hindu, 28 March, 2012, http://www.thehindu.com/todays-paper/tp-national/article3252334.ece', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'india-contests-who-figures-for-multi-drug-resistant-tb-aarti-dhar-14003', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 14003, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 13880 $metaTitle = 'LATEST NEWS UPDATES | India contests WHO figures for multi-drug resistant TB-Aarti Dhar' $metaKeywords = 'Tuberculosis,Health' $metaDesc = ' The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011...' $disp = '<div style="text-align: justify"><br /></div><div style="text-align: justify">The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence</div><div style="text-align: justify"><br /></div><div style="text-align: justify">The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Periodical exercise</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011.</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>Global annual incidence</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.</div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
India contests WHO figures for multi-drug resistant TB-Aarti Dhar |
The government on Tuesday contested the WHO figures that put the number of Multi-Drug Resistant Tuberculosis (MDR-TB) cases in India at 63,000, saying there were only 10,267. As many as 38,287 suspected cases were examined till the end of 2011 and of them, 10,267 have been diagnosed with MDR-TB and 6,994 put on treatment, according to TB India-2012 — the annual status report of the Revised National TB Control Programme (RNCTP) brought out by the Health Ministry.MDR-TB prevalence The World Health Organisation, in its report released on the eve of World TB Day, said India had an estimated 63,000 cases of notified MDR-TB in 2010, the highest in South East Asia. It also put the MDR-TB prevalence estimates at 2.3 per cent among new cases and 12-17 per cent among re-treatment cases. However, due to the size of the population and the number of TB cases reported annually, India ranks second among the 27 MDR-TB high-burden countries worldwide after China. Periodical exercise But the RNCTP report points out that most studies on drug resistant TB in India were undertaken using non-standardised methodologies with bias and small samples usually from tertiary level care facilities. To obtain a more precise estimate of MDR-TB burden, the RNTCP carried out drug resistance surveillance (DRS) in accordance with global guidelines in selected States — Gujarat, Maharashtra, Andhra Pradesh — which indicated that the prevalence of MDR-TB was low, less than 3 per cent among new cases and 12-17 per cent in re-treatment cases. To substantiate the findings, two more DRS surveys are being carried out in western Uttar Pradesh and Tamil Nadu and two more are planned in Rajasthan and Madhya Pradesh. The surveys will be undertaken to periodically monitor and study the trend of MDR prevalence. On Extensive Drug Resistant TB (XDR-TB), a subset of MDR-TB with resistance to second line drugs and injectable drugs, the report says the extent and magnitude of this problem is yet to be determined. No separate DRS surveys have been undertaken to estimate the burden of XDR-TB in the country. However, DRS surveys in Gujarat and Andhra Pradesh reported 14 XDR-TB cases and 112 XDR-TB patients were diagnosed at the National Reference Laboratories as reported by the States from 2008 to September 2011. Global annual incidence Though India is the second most populous country, it has more new TB cases annually than any other. In 2009, out of the estimated global annual incidence of 9.4 million cases, two million were estimated to have occurred in India. It is estimated about 40 per cent of the Indian population is infected with TB bacillus.
|